The investment bank has opened a negative catalyst watch ahead of Knorr-Bremse’s first-half results, with near-term truck market dynamics likely to be the primary factor influencing the stock ...

However it looks like Knorr-Bremse might be reinvesting for long term growth because while capital employed has increased, the company's sales haven't changed much in the last 12 months.

Review the current Knorr-Bremse AG ADR (KBXA:XSTU) dividend yield and history to decide if KBXA is the best investment for you.

Germany-based Knorr-Bremse has signed rail contracts with China Railway Rolling Stock Corporation (CRRC) to supply braking systems for metro projects in several cities. Knorr-Bremse will provide ...

The market for Knorr-Bremse AG's (ETR:KBX) shares didn't move much after it posted weak earnings recently. Our analysis suggests that while the profits are soft, the foundations of the business ...

View the latest Knorr-Bremse AG (KNBHF) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Introduction & Market Context Knorr-Bremse AG (ETR: KBX), a global leader in braking systems for rail and commercial vehicles, presented its Q1 2025 financial results on May 8, 2025.

Hitachi Rail has engaged Knorr-Bremse to provide various system technologies for a fleet of 30 metro trains for the City of Rome in Italy.

Knorr-Bremse AG offers solid fundamentals, strong dividends, and growth potential. Click for why KNRRY stock is rated a Buy with 20%+ RoR and a €103/share target.

What Is Knorr-Bremse Worth? Great news for investors – Knorr-Bremse is still trading at a fairly cheap price. Our valuation model shows that the intrinsic value for the stock is €123.80, which is ...

The Commissioner for Health, Dr. Abubakar Labaran Yusuf, has warned that a single tuberculosis (TB) patient who remains untreated can transmit the disease to 15-20 people within a year.